The origins, results and consequences of the 1995 Arthritis Research Campaign Low-dose Glucocorticoid Study

Clinical and Experimental Rheumatology

Volumn 29, Issue 5 SUPPL. 68, 2011, Pages

  Kirwan, J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Disease modifying anti rheumatoid drugs; Long term effects; Radiographs; Reactions to publication; Rheumatoid arthritis

Indexed keywords

GLUCOCORTICOID; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PREDNISOLONE;

ARTICLE; BLOOD PRESSURE; DRUG ACTIVITY; DRUG INDUSTRY; FOLLOW UP; GLUCOSURIA; HEALTH CARE ACCESS; HEALTH SERVICE; HUMAN; LOW DRUG DOSE; MEDICAL RESEARCH; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIDE EFFECT; WEIGHT GAIN;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CLINICAL TRIALS AS TOPIC; GLUCOCORTICOIDS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS;

EID: 81155145984     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. HENCH PS, KENDALL EC, SLOCUMB CH, POLLEY HF: Effects of a hormone of the adrenal cortex (17-hydroxy-11 dehydrocorticosterone: compound E) and of pituitary adrenocorticotrophic hormone on rheumatoid arthritis: Preliminary report. Proc Staff Meet Mayo Clin 1949; 24: 181-97.
2. HENCH PS, KENDALL EC, SLOCUMB CH et al.: Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions. Arch Intern Med 1950; 85: 545-666.
3. JOINT COMMITTEE OF THE MEDICAL RESEARCH COUNCIL AND NUFFIELD FOUNDATION: Long term results in early cases of rheumatoid arthritis treated with either cortisone or aspirin. BMJ 1957; 1: 847-51,
4. EMPIRE RHEUMATISM COUNCIL: Multicentre controlled trial comparing cortisone acetate and acetyl salicylic acid in the long-term treatment of rheumatoid arthritis. Ann Rheum Dis 1957; 16:277-89.
5. JOINT COMMITTEE OF THE MEDICAL RESEARCH COUNCIL AND NUFFIELD FOUNDATION: A comparison of prednisolone with aspirin or other compound analgesic in the treatment of rheumatoid arthritis. Ann Rheum Dis 1959; 18: 173-88.
6. WEST HF: Rheumatoid arthritis. The relevance of clinical knowledge to research activities. Abstr World Med 1967; 41: 401-17.
7. KIRWAN JR, THE ARTHRITIS AND RHEUMATISM COUNCIL LOW-DOSE GLUCOCORTICOID STUDY GROUP: The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 1995; 333: 142-6.
8. HARRIS ED, EMKEY RD, NICHOLS JE, NEWBERG A: Low dose prednisone therapy in rheumatoid arthritis: a double blind study. J Rheumatol 1983; 10: 5: 713-21. (Pubitemid 14176085)
9. BYRON MA, MOWAT AG: Corticosteroid prescribing in rheumatoid arthritis - the fiction and the fact. Br J Rheumatol 1985; 24: 164-6. (Pubitemid 15119254)
10. a. TUULIKKI S, KAUTIAINE H, TOLOZA S, MÄKINEN H, VERSTAPPEN SMM, HETLAND ML: QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis 2007; 66: 1491-6. (Pubitemid 350032658)
11. DE ANGELIS CD, DRAZEN JM, FRIZELLE FA et al.: Clinical trial registration: a statement from the International Committee of Medical Journal Editors. JAMA 2004; 292: 1363-4. (Pubitemid 39223230)
12. BYRON MA, KIRWAN JR: Corticosteroids in rheumatoid arthritis: Is a trial of their 'disease modifying' potential feasible? Ann Rheum Dis 1986; 46: 171-3. (Pubitemid 16162489)
13. DEIGHTON C, DOHERTY M: Treatment advances-when and how to inform the public? Br J Rheumatol 1996; 35: 1175-7.
14. KIRWAN J: Informing the public about treatment advances. Br J Rheumatol 1997; 36: 1026.
15. DEIGHTON C, DOHERTY M: Reply. Br J Rheumatol 1997; 36: 1026.
16. KIRWAN JR: Lumping and splitting when assessing arthritis. J Rheumatol 1994; 21: 6-7. (Pubitemid 24044908)
17. KIRWAN JR: Making original data from clinical studies available for alternative analysis. J Rheumatol 1997; 24: 822-5. (Pubitemid 27223612)
18. HICKLING P, JACOBY RK, KIRWAN JR: Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis. Br J Rheumatol 1998; 37: 930-6.
19. KIRWAN JR, CURREY HLF: Rheumatoid arthritis - disease-modifying anti-rheumatic drugs. Clin Rheum Dis 1983; 9: 581-99. (Pubitemid 14241812)
20. KIRWAN JR: The synovium in rheumatoid arthritis - evidence for (at least) two patholologies. Arthritis Rheum 2004; 50: 1-4. (Pubitemid 38084281)
21. KIRWAN JR, BYRON M, WATT I: Relationship between soft tissue swelling, joint space narrowing and erosive damage in hand x-rays of patients with rheumatoid arthritis. Rheumatology 2001;40:297-301.
22. MCQUEEN F, NAREDO E: The 'disconnect' between synovitis and erosion in rheumatoid arthritis: a result of treatment or intrinsic to the disease process itself? Ann Rheum Dis 2011;70:241-4.
23. BOERS M, VERHOEVEN AC, MARKUSSE HM et al.: Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997; 350: 309-18. (Pubitemid 27351112)
24. NATIONAL COLLABORATING CENTRE FOR CHRONIC CONDITIONS: Rheumatoid arthritis: national clinical guideline for management and treatment in adults. London: Royal College of Physicians, February 2009. http://www.nice.org.uk/ nicemedia/pdf/CG79NICEGuideline.pdf
25. MOESER PJ: Corticosteroid therapy for rheumatoid arthritis. Benefits and limitations. Postgrad Med 1991; 90: 175-6, 178-82.
26. KIRWAN JR, BIJLSMA JWJ, BOERS M, SHEA BJ: Effects of glucocorticoids on radiological progression in rheumatoid arthritis. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD006356. DOI: 10.1002/14651858. CD006356 (Pubitemid 351835439)
27. VAN SCHAARDENBURG D, VALKEMA R, DIJKMANS BAC et al.: Prednisone treatment of elderly-onset rheumatoid arthritis: disease activity; and bone mass in comparison with chloroquine treatment. Arthritis Rheum 1995; 38: 334-42.
28. VAN GESTEL AM, LAAN RFJM, HAAGSMA CL, VAN DE PUTTE LBA, VAN RIEL PLCM: Low-dose oral steroids as bridge therapy in rheumatoid arthritis patients starting with parenteral gold: A randomized double-blind placebo-controlled trial. Br J Rheumatol 1995;34:347-51.
29. VAN EVERDINGEN AA, JACOBS JWG, SIEWERTSZ VAN REESEMA DR, BIJLSMA JWJ: Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: A randomized, double-blind, placebo-controlled clinical trial. Ann Intern Med 2002; 136: 1-12. (Pubitemid 34038692)
30. SUPONITSKAIA EV, SMIRNOV AV, ALEKSANDROVA EN, NOVIKOV AA, NASONOV EL: Effect of small-dose glucocorticoids on the course of early rheumatic arthritis. Klinicheskaia Meditsina 2004; 82: 39-42.
31. CAPELL HA, MADHOK R, HUNTER JA et al.: Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial. Ann Rheum Dis 2004; 63: 797-803. (Pubitemid 38850450)
32. SVENSSON B, BOONEN A, ALBERTSSON K, VAN DER HEIJDE D, KELLER C, HAFSTROM I, for the BARFOT STUDY GROUP: Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate - a two-year randomized trial. Arthritis Rheum 2005; 52: 3360-70. (Pubitemid 41612202)
33. GOEKOOP-RUITERMAN YPM. DE VRIESBOUWSTRA JK, ALLAART CF et al.: Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeST study) - A randomized, controlled trial. Arthritis Rheum 2005; 52: 3381-90. (Pubitemid 41612204)
34. WASSENBERG S, RAU R, STEINFELD P, ZEIDLER H, for the LOW-DOSE PREDNISOLONE THERAPY STUDY GROUP: Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years - A multicenter, double-blind, placebocontrolled trial. Arthritis Rheum 2005; 33: 71-80.
35. CHOY EH, KINGSLEY GH, KHOSHABA B, PIPITONE N, SCOTT DL: Disease modifying anti-rheumatic drugs arthritis who have shown an incomplete response to steroids in patients with established rheumatoid A two year randomised controlled trial of IM depot. Ann Rheum Dis 2005; 64: 1288-93. (Pubitemid 41206244)